ANPEP and non-small cell lung carcinoma: Studies on NSCLC demonstrated that the expression of APN/CD13 was associated with angiogenesis, TNM stage and lymph node metastasis status; and that patients with APN/CD13 positive tumors had a significantly lower five-year survival rate than patients with APN/CD13 negative tumors [13, 14].